Salix Pharmaceuticals (SLXP)
Create an Alert
66.82
+0.60 +0.91%
NASDAQ
Jun 18, 5:00PM
BATS Real time
Currency in USD
Salix Pharmaceuticals Shareholders Equity:
586.68M for March 31, 2013Salix Pharmaceuticals Historical Shareholders Equity Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 586.68M |
| Dec. 31, 2012 | 560.50M |
| Sept. 30, 2012 | 532.60M |
| June 30, 2012 | 504.42M |
| March 31, 2012 | 475.33M |
| Dec. 31, 2011 | 549.64M |
| Sept. 30, 2011 | 480.43M |
| June 30, 2011 | 438.92M |
| March 31, 2011 | 407.84M |
| Dec. 31, 2010 | 401.92M |
| Sept. 30, 2010 | 370.06M |
| June 30, 2010 | 369.43M |
| March 31, 2010 | 353.49M |
| Dec. 31, 2009 | 370.02M |
| Sept. 30, 2009 | 237.42M |
| June 30, 2009 | 239.84M |
| March 31, 2009 | 253.16M |
| Dec. 31, 2008 | 265.40M |
| Sept. 30, 2008 | 259.60M |
| June 30, 2008 | 263.71M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Shareholders' Equity
Shareholders' equity is difference between a company's total assets and total liabilities. Also referred to as stockholders' equity, net worth, or net assets.
Learn More
SLXP Shareholders Equity Benchmarks
| Companies | |
|---|---|
| Jazz Pharmaceuticals | 1.162B |
| Santarus | 107.06M |
| Valeant Pharmaceuticals International | 3.587B |
SLXP Shareholders Equity Rankings
| Overall |
80th percentile 3317 of 16773 |
| Sector |
86th percentile 192 of 1408 in Healthcare |
| Industry |
82nd percentile 26 of 152 in Drug Manufacturers - Specialty & Generic |
SLXP Shareholders Equity Range, Past 5 Years
| Minimum | 237.41M | Sep 2009 |
| Maximum | 586.68M | Mar 2013 |
| Average | 396.02M |
